Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Aviron intranasal influenza vaccine

Executive Summary

Aviron intranasal influenza vaccine: Phase III trial will enroll over 900 children aged 15-71 months by year-end, Mountain View, Calif.-based Aviron announces Aug. 26. Aviron will conduct the randomized, double-blind, placebo-controlled trial in collaboration with the National Institute of Allergy & Infectious Disease; Aviron entered a Collaborative Research & Development Agreement with NIAID in 1995. The pivotal trial will test the "reduction of disease associated with influenza virus infection," examining illness including fever, respiratory tract symptoms, muscle aches, chills, decreased activity and irritability. Phase III trials of the intranasal vaccine in the elderly and adults are planned for 1997. Aviron will seek funding through a small private placement this autumn or through a public offering if the stock market improves. The company postponed an initial public offering in July...
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS028774

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel